Original-Research: Epigenomics AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Epigenomics AG Unternehmen: Epigenomics AG ISIN: DE000A11QW50 Anlass der Studie: Update Empfehlung: BUY seit: 19.12.2017 Kursziel: €7,30 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: 06.10.2017; vormals Add Analyst: Simon Scholes, CFA First Berlin Equity Research has […]
Year: 2017
19. December 2017
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH)
19. December 2017
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH)
Original-Research: Epigenomics AG – von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Epigenomics AG Unternehmen: Epigenomics AG ISIN: DE000A11QW50 Anlass der Studie: Update Empfehlung: BUY seit: 19.12.2017 Kursziel: €7,30 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: 06.10.2017; vormals Add Analyst: Simon Scholes, CFA First Berlin Equity Research has […]
19. December 2017
Epigenomics AG gets CE-IVD Mark for Lung Cancer Test Epi proLung(R)
DGAP-News: Epigenomics AG / Key word(s): Product Launch 19.12.2017 / 08:45 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG gets CE-IVD Mark for Lung Cancer Test Epi proLung(R) Berlin (Germany) and Germantown, MD (U.S.A.), December 19, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY, “Company”) announced […]
29. November 2017
Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand)
DGAP-News: Epigenomics AG / Key word(s): Change of Personnel 29.11.2017 / 21:41 The issuer is solely responsible for the content of this announcement. Press release Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand) Berlin (Germany) and Germantown, MD (U.S.A.), November 29, 2017 […]
21. November 2017
Epigenomics AG announces recent payment decision by CMS
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 21.11.2017 / 22:35 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG announces recent payment decision by CMS Berlin (Germany) and Germantown, MD (U.S.A.), November 21, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced the Centers of Medicare & […]
15. November 2017
Epigenomics AG Announces 2017 Third Quarter and Nine Months Financial Results
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 15.11.2017 / 08:35 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2017 Third Quarter and Nine Months Financial Results – Third quarter performance in line with expectations; 2017 adj. EBITDA outlook improved – Financial position significantly strengthened […]